ArticleScientific reports2024

A real-world pharmacovigilance analysis of potential ototoxicity associated with sacubitril/valsartan based on FDA Adverse Event Reporting System (FAERS).

Ning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.